{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:49:20Z","timestamp":1788299360108,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.vaccine.2021.03.059","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T06:25:55Z","timestamp":1617258355000},"page":"2561-2567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis"],"prefix":"10.1016","volume":"39","author":[{"given":"M.J.","family":"Klouwens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.M.","family":"Salverda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Trentelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.I.","family":"Ersoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wagemakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.H.","family":"Gerritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"van der Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.03.059_b0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.059_b0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13000-018-0768-y","article-title":"Bacterial outer membrane vesicles, a potential vaccine candidate in interactions with host cells based","volume":"13","author":"Cai","year":"2018","journal-title":"Diagn Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.03.059_b0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2958.2006.05522.x","article-title":"Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response","volume":"63","author":"McBroom","year":"2007","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.059_b0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/jb.136.1.280-285.1978","article-title":"Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins","volume":"136","author":"Sonntag","year":"1978","journal-title":"J Bacteriol"},{"issue":"30","key":"10.1016\/j.vaccine.2021.03.059_b0025","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1016\/j.vaccine.2010.04.082","article-title":"Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process","volume":"28","author":"van de Waterbeemd","year":"2010","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.03.059_b0030","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.vaccine.2016.01.019","article-title":"Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles","volume":"34","author":"Salverda","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.03.059_b0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/589308","article-title":"Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin","volume":"198","author":"Koeberling","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.03.059_b0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.addr.2017.05.003","article-title":"Designer outer membrane vesicles as immunomodulatory systems - Reprogramming bacteria for vaccine delivery","volume":"114","author":"Gnopo","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.059_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2021.03.059_b0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/IAI.00950-10","article-title":"Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae","volume":"79","author":"Muralinath","year":"2011","journal-title":"Infect Immun"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2021.03.059_b0055","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.03.059_b0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2014.00121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"5","author":"Acevedo","year":"2014","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.03.059_b0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: a multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2021.03.059_b0070","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.179.11.7692","article-title":"Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo","volume":"179","author":"Alaniz","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2021.03.059_b0075","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24015","article-title":"Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen","volume":"3","author":"Fantappi\u00e8","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.vaccine.2021.03.059_b0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fcimb.2018.00132","article-title":"Immunization With Skp Delivered on Outer Membrane Vesicles Protects Mice Against Enterotoxigenic Escherichia coli Challenge","volume":"8","author":"Hays","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.03.059_b0085","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1128\/iai.61.4.1460-1467.1993","article-title":"Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi","volume":"61","author":"Whitmire","year":"1993","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2021.03.059_b0090","first-page":"599","article-title":"Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic","volume":"12","author":"Aaberge","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.03.059_b0095","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/CVI.00094-07","article-title":"Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines","volume":"14","author":"Sandbu","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2021.03.059_b0100","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0264-410X(99)00423-5","article-title":"Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2\u20133 and 7\u20138 years of age","volume":"18","author":"de Kleijn","year":"2000","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2021.03.059_b0105","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/CVI.00406-14","article-title":"A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato","volume":"21","author":"Wressnigg","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2021.03.059_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and development of a novel vaccine for protection against Lyme borreliosis","volume":"9","author":"Comstedt","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2021.03.059_b0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2021.03.059_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066536","article-title":"Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa","volume":"8","author":"Pajon","year":"2013","journal-title":"PLoS ONE"},{"issue":"47","key":"10.1016\/j.vaccine.2021.03.059_b0125","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1016\/j.vaccine.2019.01.076","article-title":"Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification","volume":"37","author":"Gerritzen","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.059_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054314","article-title":"Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development","volume":"8","author":"van de Waterbeemd","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.059_b0135","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1038\/s41598-019-41233-x","article-title":"Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis","volume":"9","author":"Gerritzen","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.059_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12934-018-1007-7","article-title":"High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis","volume":"17","author":"Gerritzen","year":"2018","journal-title":"Microb Cell Fact"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.059_b0145","doi-asserted-by":"crossref","first-page":"1333883","DOI":"10.1080\/20013078.2017.1333883","article-title":"High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production","volume":"6","author":"Gerritzen","year":"2017","journal-title":"J Extracell Vesicles"},{"issue":"28","key":"10.1016\/j.vaccine.2021.03.059_b0150","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1016\/j.vaccine.2005.02.006","article-title":"Multicomponent Lyme vaccine: three is not a crowd","volume":"23","author":"Brown","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2021.03.059_b0155","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0264-410X(93)90132-H","article-title":"Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA\/OspB genotype","volume":"11","author":"Schaible","year":"1993","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2021.03.059_b0160","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/gt.2014.87","article-title":"Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection","volume":"21","author":"Wagemakers","year":"2014","journal-title":"Gene Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2021.03.059_b0165","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2021.03.059_b0170","unstructured":"Golos, A. and A. Lutynska, Aluminium-adjuvanted vaccines--a review of the current state of knowledge. Przegl Epidemiol, 2015. 69(4): p. 731-4, 871-4."},{"key":"10.1016\/j.vaccine.2021.03.059_b0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1742-2094-8-36","article-title":"Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study","volume":"8","author":"Henningsson","year":"2011","journal-title":"J Neuroinflammation"},{"issue":"5428","key":"10.1016\/j.vaccine.2021.03.059_b0180","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"issue":"5508","key":"10.1016\/j.vaccine.2021.03.059_b0185","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.291.5508.1544","article-title":"Induction of direct antimicrobial activity through mammalian toll-like receptors","volume":"291","author":"Thoma-Uszynski","year":"2001","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2021.03.059_b0190","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1208\/s12248-016-9979-x","article-title":"The Dual Role of Lipids of the Lipoproteins in Trumenba, a Self-Adjuvanting Vaccine Against Meningococcal Meningitis B Disease","volume":"18","author":"Luo","year":"2016","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.vaccine.2021.03.059_b0195","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2021.03.059_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124416","article-title":"OMV Vaccines and the Role of TLR Agonists in Immune Response","volume":"21","author":"Mancini","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2021.03.059_b0205","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1080\/21645515.2019.1627159","article-title":"Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults","volume":"15","author":"Martin\u00f3n-Torres","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2021.03.059_b0210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biotechadv.2017.05.003","article-title":"Bioengineering bacterial outer membrane vesicles as vaccine platform","volume":"35","author":"Gerritzen","year":"2017","journal-title":"Biotechnol Adv"},{"issue":"17","key":"10.1016\/j.vaccine.2021.03.059_b0215","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.vaccine.2015.03.010","article-title":"Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization","volume":"33","author":"Kuipers","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.03.059_b0220","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/CVI.00542-10","article-title":"A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines","volume":"18","author":"Koeberling","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.03.059_b0225","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00917-19","article-title":"Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment","volume":"88","author":"Nayak","year":"2020","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2021.03.059_b0230","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1073\/pnas.87.10.3768","article-title":"Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice","volume":"87","author":"Schaible","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4980","key":"10.1016\/j.vaccine.2021.03.059_b0235","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.2237407","article-title":"Protection of mice against the Lyme disease agent by immunizing with recombinant OspA","volume":"250","author":"Fikrig","year":"1990","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2021.03.059_b0240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(94)00027-K","article-title":"The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi","volume":"13","author":"Golde","year":"1995","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.03.059_b0245","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2595","article-title":"Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions","volume":"30","author":"Shandilya","year":"2017","journal-title":"J Mol Recognit"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21003637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21003637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:55:06Z","timestamp":1759402506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21003637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":49,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0264410X21003637"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}